Boothbay Fund Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-43,420
Closed -$2.05M 2591
2022
Q3
$2.05M Buy
43,420
+5,413
+14% +$350K 0.05% 563
2022
Q2
$2.72M Sell
38,007
-13,706
-27% -$1M 0.07% 418
2022
Q1
$4.19M Buy
51,713
+46,663
+924% +$3.95M 0.1% 264
2021
Q4
$519K Sell
5,050
-105,578
-95% -$10.1M 0.01% 998
2021
Q3
$9.68M Buy
110,628
+7,403
+7% +$670K 0.27% 63
2021
Q2
$9.24M Buy
103,225
+42,293
+69% +$3.57M 0.3% 65
2021
Q1
$4.62M Sell
60,932
-18,380
-23% -$1.39M 0.17% 112
2020
Q4
$5.4M Buy
79,312
+23,965
+43% +$1.49M 0.2% 90
2020
Q3
$2.94M Buy
55,347
+35,108
+173% +$2.09M 0.18% 135
2020
Q2
$1.18M Buy
20,239
+4,801
+31% +$258K 0.08% 336
2020
Q1
$609K Sell
15,438
-21,400
-58% -$1.25M 0.05% 417
2019
Q4
$2.19M Buy
36,838
+6,905
+23% +$371K 0.19% 139
2019
Q3
$1.59M Buy
+29,933
New +$1.54M 0.15% 192

Other funds holding SYNH

Boothbay Fund Management's SYNH Position: Q4 2022 in Review

Boothbay Fund Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 43,420 shares — an estimated $2.05M sold.

Boothbay Fund Management first reported a position in SYNH in Q3 2019 and held it in 13 quarters. The position peaked at $9.68M in Q3 2021. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

  • Boothbay Fund Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Boothbay Fund Management sold 43,420 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $2.05M.
  • Boothbay Fund Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2019 and held it in 13 quarters.
  • Boothbay Fund Management's Syneos Health, Inc. Class A Common Stock position peaked at $9.68M in Q3 2021.
  • 307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Boothbay Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.